NASACORT ALLERGY 24HR OTC
Generic Name and Formulations:
Triamcinolone acetonide 55mcg; per nasal spray; scent- and alcohol-free.
Indications for NASACORT ALLERGY 24HR:
Seasonal and perennial allergic rhinitis, including nasal congestion.
2 sprays in each nostril once daily. Reduce dose as symptoms improve.
<2yrs: not recommended. 2–<6yrs: 1 spray in each nostril once daily. 6–12yrs: 1 spray in each nostril once daily; max 2 sprays in each nostril once daily. Reduce dose as symptoms improve.
Avoid use in patients with recent nasal ulcers, surgery, or injury that has not healed. Infections (eg, ocular herpes simplex). Glaucoma. Cataracts. Discontinue if exposed to measles, chickenpox, or tuberculosis. Monitor for growth suppression in children. Avoid eyes or mucous membranes. Reevaluate if no improvement after 1 week. Pregnancy. Nursing mothers.
Avoid concomitant other steroid-containing products.
Infection, fever, visual changes, severe or frequent nosebleeds.
Nasal Spray—8.25g (60 sprays), 16.5g (120 sprays); Children's—8.25g (60 sprays)
Neurology Advisor Articles
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- Patients With Multiple Sclerosis Face Greater Infection Risk
- Fingolimod Compared With Glatiramer Acetate in Head-to-Head MS Study
- Lower Relapse Risk and Disability Progression With Oral DMT in Treatment-Naive RRMS
- Anodal tDCS Offers Possible Benefit for Improving Item Recall in Post-Stroke Aphasia
- Hospitalization Tied to Brain Abnormalities in Older Adults
- Spending Often Persists in High-Cost Medicare-Medicaid Eligible
- Skills-Based Intervention Did Not Cut Systolic BP After Stroke, TIA
- High Frequency of Headaches Following Dialysis Associated With BUN and Blood Pressure